In this issue of Immunology and Allergy Clinics, guest editors Joshua Solomon and Kevin Brown bring their considerable expertise to the topic of Interstitial Lung Disease. Top experts address topics such as IPF and other PF-ILDs, Post-Covid ILD, CTLD-ILD, Sarcoidosis, and more.
Key Features
-
Contains 14 practice-oriented topics including Pulmonary Vasculitis and Alveolar Hemorrhage; Eosinophilic Interstitial Lung Diseases; Occupational Lung Disease; Smoking-related ILD; LAM and other cystic lung diseases; and more.
-
Provides in-depth clinical reviews of interstitial lung disease, offering actionable insights for clinical practice.
-
Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Author Information
Edited by Kevin K Brown, MD, National Jewish Health and Joshua J. Solomon, MD, Director, Interstitial Lung Disease Program, Associate Professor, Department of Medicine Division of Pulmonary, Critical Care & Sleep ,Medicine Section of Critical Care Medicine, National Jewish Health
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
Connective Tissue Disease Associated Interstitial Lung Disease
Hypersensitivity Pneumonitis: Updates in Evaluation, Management, and Ongoing Dilemmas
Sarcoidosis
Smoking-Related Interstitial Lung Diseases
Eosinophilic Lung Diseases
Occupational Interstitial Lung Diseases
Drug-Induced Interstitial Lung Diseases
Lymphangioleiomyomatosis and Other Cystic Lung Diseases
Interstitial Lung Disease and Anti-Neutrophil Cytoplasmic Antibody–Associated Vasculitis: A Review
Post-COVID Interstitial Lung Disease—The Tip of the Iceberg
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease